To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

The Effect of Low-Dose Radiotherapy for Painful Osteoarthritis: Final Results of the ArthroRad trial

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2024

The Effect of Low-Dose Radiotherapy for Painful Osteoarthritis: Final Results of the ArthroRad trial

Vol: 306| Issue: 4| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis-final results after 12-month follow-up.

Strahlenther Onkol . 2024 Feb;200(2):134-142.

Contributing Authors:
M Niewald S Moumeniahangar LN Muller MG Hautmann Y Dzierma J Fleckenstein S Graber C Rube M Hecht P Melchior

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

A total of 229 joints in 133 patients with clinical osteoarthritis of the hand/finger and knee joints were randomly assigned to receive either standard dose radiotherapy (total dose 3.0Gy, 0.5Gy twice weekly; n=110) or experimental low-dose radiotherapy (total dose 0.3Gy, 0.05Gy twice weekly; n=111). The primary outcome of interest was pain relief as measured by visual analog scale (VAS) scores. S...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue